METASTATIC PANCREATIC CANCER: CAN SEQUENTIAL TREATMENT WITH INFUSIONAL 5-FU AND GEMCITABINE IMPROVE SURVIVAL? A SINGLE INSTITUTION EXPERIENCE

被引：0
|
作者：
Ferreira, A. [1 ]
Ribeiro, J. [1 ]
Bonito, N. [1 ]
Broco, S. [1 ]
Jacinto, P. [1 ]
Figueiredo, P. [1 ]
Gervasio, H. [1 ]
机构：
[1] Portuguese Inst Oncol, Coimbra, Portugal
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [1] Gemcitabine/5-FU/leucovorin for the treatment of pancreatic cancer
    Malayeri, R.
    Boland, M. Ghassem
    Maadi, A. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] Comparison of 5-FU and leucovorin to gemcitabine in the treatment of pancreatic cancer
    Klein, B
    Sadikov, E
    Mishaeli, M
    Levin, I
    Figer, A
    ONCOLOGY REPORTS, 2000, 7 (04) : 875 - 877
  • [3] In vitro sensitivity to 5-FU and gemcitabine in pancreatic cancer
    Franko, J.
    Bilimoria, M. M.
    Chalikonda, S.
    Iannitti, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [4] Irinotecan in second-line treatment of metastatic colorectal cancer: Improved survival and cost-effect compared with infusional 5-FU
    Iveson, TJ
    Hickish, T
    Schmitt, C
    Van Cutsem, E
    EUROPEAN JOURNAL OF CANCER, 1999, 35 (13) : 1796 - 1804
  • [5] Chemoradiotherapy with Gemcitabine and Continuous 5-FU in Patients with Primary Inoperable Pancreatic Cancer
    Wilkowski, Ralf
    Thoma, Martin
    Bruns, Christiane
    Wagner, Andreas
    Heinemann, Volker
    JOURNAL OF THE PANCREAS, 2006, 7 (04): : 349 - 360
  • [6] Vinorelbine and infusional 5-FU (VIF) - a phase II study in metastatic breast cancer.
    Stuart, N
    Bishop, J
    McIllmurray, M
    Price, C
    Johnston, SRD
    O'Reilly, S
    Joffe, J
    Neave, F
    Perren, T
    Crosby, T
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S91 - S91
  • [7] SEQUENTIAL METHOTREXATE AND 5-FU IN THE TREATMENT OF COLORECTAL-CANCER
    WEINERMAN, B
    SCHACTER, B
    SCHIPPER, H
    BOWMAN, D
    LEVITT, M
    CANCER TREATMENT REPORTS, 1982, 66 (07): : 1553 - 1555
  • [8] Development of treatment for advanced colorectal cancer: Infusional 5-FU and the role of new agents
    Schmoll, HJ
    EUROPEAN JOURNAL OF CANCER, 1996, 32A : S18 - S22
  • [9] Retrospective trial of concurrent gemcitabine (GEM) or infusional 5-fluoruracil (5-FU), folinic acid (FA), interferon (IFN) treatment in patients with locally advanced or metastatic pancreatic adenocarcinoma.
    Eickhoff, AS
    Jakobs, R
    Riemann, JF
    GASTROENTEROLOGY, 2000, 118 (04) : A517 - A517
  • [10] Gemcitabine and protracted 5-FU for advanced pancreatic cancer.: A phase II study
    Kurtz, JE
    Kohser, F
    Négrier, S
    Trillet-Lenoir, V
    Walter, S
    Limacher, JM
    Untereiner, M
    Kayitalire, L
    Jaeck, D
    Dufour, P
    HEPATO-GASTROENTEROLOGY, 2000, 47 (35) : 1450 - 1453
12345